Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	low-density lipoprotein particle binding	SCARF1 STAB2 STAB1	2.72e-06	18	31	3	GO:0030169
GeneOntologyMolecularFunction	integrin binding	LAMA5 ADAMTS13 TNC TNXB SVEP1	6.90e-06	175	31	5	GO:0005178
GeneOntologyMolecularFunction	scavenger receptor activity	SCARF1 STAB2 STAB1	9.66e-06	27	31	3	GO:0005044
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA2 LAMA5 SSPOP TNC TNXB	9.77e-06	188	31	5	GO:0005201
GeneOntologyMolecularFunction	calcium ion binding	DLK2 ADAMTS13 STAB2 ADGRE2 MEGF6 MEGF8 SVEP1 STAB1	1.38e-05	749	31	8	GO:0005509
GeneOntologyMolecularFunction	lipoprotein particle binding	SCARF1 STAB2 STAB1	2.14e-05	35	31	3	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	SCARF1 STAB2 STAB1	2.14e-05	35	31	3	GO:0071814
GeneOntologyMolecularFunction	glycosaminoglycan binding	CRISPLD2 STAB2 ADGRE2 TNXB STAB1	5.36e-05	268	31	5	GO:0005539
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	STAB2 STAB1	2.76e-04	16	31	2	GO:0005041
GeneOntologyMolecularFunction	cargo receptor activity	SCARF1 STAB2 STAB1	3.07e-04	85	31	3	GO:0038024
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	STAB2 STAB1	4.81e-04	21	31	2	GO:0030228
GeneOntologyMolecularFunction	hyaluronic acid binding	STAB2 STAB1	9.23e-04	29	31	2	GO:0005540
GeneOntologyMolecularFunction	protein-disulfide reductase activity	STAB2 STAB1	1.42e-03	36	31	2	GO:0015035
GeneOntologyMolecularFunction	disulfide oxidoreductase activity	STAB2 STAB1	2.02e-03	43	31	2	GO:0015036
GeneOntologyMolecularFunction	cell adhesion molecule binding	LAMA5 ADAMTS13 TNC TNXB SVEP1	2.13e-03	599	31	5	GO:0050839
GeneOntologyMolecularFunction	oxidoreductase activity, acting on a sulfur group of donors	STAB2 STAB1	3.53e-03	57	31	2	GO:0016667
GeneOntologyMolecularFunction	endopeptidase activity	MST1 ADAM33 ADAMTS13 PLG	4.21e-03	430	31	4	GO:0004175
GeneOntologyMolecularFunction	structural molecule activity	LAMA2 LAMA5 SSPOP TNC TNXB	1.13e-02	891	31	5	GO:0005198
GeneOntologyMolecularFunction	sulfur compound binding	CRISPLD2 ADGRE2 TNXB	1.35e-02	323	31	3	GO:1901681
GeneOntologyMolecularFunction	metalloendopeptidase activity	ADAM33 ADAMTS13	1.49e-02	120	31	2	GO:0004222
GeneOntologyBiologicalProcess	extracellular matrix organization	LAMA2 CRISPLD2 ADAMTS13 PLG ADAMTSL4 TNXB	1.19e-05	377	29	6	GO:0030198
GeneOntologyBiologicalProcess	extracellular structure organization	LAMA2 CRISPLD2 ADAMTS13 PLG ADAMTSL4 TNXB	1.21e-05	378	29	6	GO:0043062
GeneOntologyBiologicalProcess	external encapsulating structure organization	LAMA2 CRISPLD2 ADAMTS13 PLG ADAMTSL4 TNXB	1.23e-05	379	29	6	GO:0045229
GeneOntologyCellularComponent	extracellular matrix	LAMA2 MST1 CRISPLD2 LAMA5 ADAMTS13 PLG MEGF6 SSPOP TNC ADAMTSL4 TNXB SVEP1	4.26e-11	656	30	12	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	LAMA2 MST1 CRISPLD2 LAMA5 ADAMTS13 PLG MEGF6 SSPOP TNC ADAMTSL4 TNXB SVEP1	4.41e-11	658	30	12	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	LAMA2 MST1 LAMA5 PLG MEGF6 SSPOP TNC ADAMTSL4 TNXB	3.60e-08	530	30	9	GO:0062023
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA2 TNC TNXB	1.79e-06	17	30	3	GO:0098637
GeneOntologyCellularComponent	tenascin complex	TNC TNXB	1.19e-05	4	30	2	GO:0090733
GeneOntologyCellularComponent	protein complex involved in cell adhesion	LAMA2 TNC TNXB	8.21e-05	59	30	3	GO:0098636
GeneOntologyCellularComponent	synapse-associated extracellular matrix	LAMA5 TNC	1.54e-04	13	30	2	GO:0099535
GeneOntologyCellularComponent	interstitial matrix	TNC ADAMTSL4	2.67e-04	17	30	2	GO:0005614
GeneOntologyCellularComponent	basement membrane	LAMA2 LAMA5 TNC	7.02e-04	122	30	3	GO:0005604
GeneOntologyCellularComponent	synaptic cleft	LAMA2 LAMA5	1.02e-03	33	30	2	GO:0043083
GeneOntologyCellularComponent	endocytic vesicle membrane	SCARF1 STAB2 STAB1	3.41e-03	212	30	3	GO:0030666
GeneOntologyCellularComponent	external side of plasma membrane	STAB2 PLG ADGRE2 IL21R	6.17e-03	519	30	4	GO:0009897
Domain	EGF_1	SCARF1 DLK2 LAMA2 LAMA5 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 SSPOP TNC TNXB MEGF11 SVEP1 STAB1	1.75e-20	255	31	15	PS00022
Domain	EGF_2	SCARF1 DLK2 LAMA2 LAMA5 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 SSPOP TNC TNXB MEGF11 SVEP1 STAB1	3.14e-20	265	31	15	PS01186
Domain	EGF	SCARF1 DLK2 LAMA2 LAMA5 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 TNC TNXB MEGF11 SVEP1 STAB1	3.70e-19	235	31	14	SM00181
Domain	EGF-like_dom	SCARF1 DLK2 LAMA2 LAMA5 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 TNC TNXB MEGF11 SVEP1 STAB1	8.42e-19	249	31	14	IPR000742
Domain	EGF-like_CS	SCARF1 DLK2 LAMA2 LAMA5 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 TNC TNXB MEGF11 SVEP1 STAB1	1.64e-18	261	31	14	IPR013032
Domain	EGF_extracell	SCARF1 DLK2 ADAM33 STAB2 MEGF6 TNC TNXB MEGF11 SVEP1 STAB1	2.24e-18	60	31	10	IPR013111
Domain	EGF_2	SCARF1 DLK2 ADAM33 STAB2 MEGF6 TNC TNXB MEGF11 SVEP1 STAB1	2.24e-18	60	31	10	PF07974
Domain	EGF_3	SCARF1 DLK2 ADAM33 STAB2 ADGRE2 MEGF6 MEGF8 SSPOP TNC TNXB MEGF11 SVEP1 STAB1	2.40e-17	235	31	13	PS50026
Domain	Laminin_EGF	SCARF1 LAMA2 LAMA5 STAB2 MEGF6 MEGF8 MEGF11 STAB1	1.02e-15	38	31	8	IPR002049
Domain	Growth_fac_rcpt_	SCARF1 LAMA5 STAB2 ADGRE2 MEGF6 MEGF8 TNC TNXB SVEP1 STAB1	4.71e-14	156	31	10	IPR009030
Domain	Laminin_EGF	SCARF1 LAMA2 LAMA5 MEGF6 MEGF8 MEGF11 STAB1	1.09e-13	35	31	7	PF00053
Domain	EGF_Lam	LAMA2 LAMA5 STAB2 MEGF6 MEGF8 MEGF11 STAB1	1.09e-13	35	31	7	SM00180
Domain	EGF_CA	DLK2 STAB2 ADGRE2 MEGF6 MEGF8 SVEP1 STAB1	9.85e-10	122	31	7	SM00179
Domain	EGF-like_Ca-bd_dom	DLK2 STAB2 ADGRE2 MEGF6 MEGF8 SVEP1 STAB1	1.10e-09	124	31	7	IPR001881
Domain	EGF	DLK2 STAB2 MEGF6 TNC TNXB SVEP1 STAB1	1.24e-09	126	31	7	PF00008
Domain	EGF_LAM_2	LAMA2 LAMA5 STAB2 MEGF8 STAB1	1.24e-09	30	31	5	PS50027
Domain	EGF_LAM_1	LAMA2 LAMA5 STAB2 MEGF8 STAB1	1.24e-09	30	31	5	PS01248
Domain	hEGF	DLK2 MEGF6 MEGF11 SVEP1	1.24e-07	28	31	4	PF12661
Domain	EGF_Ca-bd_CS	DLK2 ADGRE2 MEGF6 MEGF8 SVEP1	5.20e-07	97	31	5	IPR018097
Domain	EGF_CA	DLK2 ADGRE2 MEGF6 MEGF8 SVEP1	5.76e-07	99	31	5	PS01187
Domain	ASX_HYDROXYL	DLK2 ADGRE2 MEGF6 MEGF8 SVEP1	6.05e-07	100	31	5	PS00010
Domain	-	STAB2 SVEP1 STAB1	6.77e-07	11	31	3	2.40.155.10
Domain	GFP-like	STAB2 SVEP1 STAB1	6.77e-07	11	31	3	IPR023413
Domain	EGF-type_Asp/Asn_hydroxyl_site	DLK2 ADGRE2 MEGF6 MEGF8 SVEP1	8.09e-07	106	31	5	IPR000152
Domain	EGF_3	STAB2 MEGF8 STAB1	9.02e-07	12	31	3	PF12947
Domain	EGF_dom	STAB2 MEGF8 STAB1	9.02e-07	12	31	3	IPR024731
Domain	EMI	MEGF6 SSPOP MEGF11	2.77e-06	17	31	3	PS51041
Domain	EGF_CA	ADGRE2 MEGF6 MEGF8 SVEP1	1.20e-05	86	31	4	PF07645
Domain	-	STAB2 STAB1	1.60e-05	4	31	2	2.30.180.10
Domain	FAS1	STAB2 STAB1	1.60e-05	4	31	2	SM00554
Domain	FAS1	STAB2 STAB1	1.60e-05	4	31	2	PS50213
Domain	Fasciclin	STAB2 STAB1	1.60e-05	4	31	2	PF02469
Domain	FAS1_domain	STAB2 STAB1	1.60e-05	4	31	2	IPR000782
Domain	PAN_AP	MST1 PLG	2.66e-05	5	31	2	SM00473
Domain	Laminin_aI	LAMA2 LAMA5	2.66e-05	5	31	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA5	2.66e-05	5	31	2	PF06008
Domain	Laminin_II	LAMA2 LAMA5	2.66e-05	5	31	2	PF06009
Domain	Laminin_domII	LAMA2 LAMA5	2.66e-05	5	31	2	IPR010307
Domain	PAN	MST1 PLG	5.57e-05	7	31	2	PS50948
Domain	Pan_app	MST1 PLG	5.57e-05	7	31	2	IPR003609
Domain	PAN_1	MST1 PLG	5.57e-05	7	31	2	PF00024
Domain	LAMININ_IVA	LAMA2 LAMA5	7.42e-05	8	31	2	PS51115
Domain	Laminin_B	LAMA2 LAMA5	7.42e-05	8	31	2	PF00052
Domain	LamB	LAMA2 LAMA5	7.42e-05	8	31	2	SM00281
Domain	Laminin_IV	LAMA2 LAMA5	7.42e-05	8	31	2	IPR000034
Domain	CUB	ADAMTS13 CSMD2 MEGF8	9.17e-05	53	31	3	PS01180
Domain	CUB_dom	ADAMTS13 CSMD2 MEGF8	1.14e-04	57	31	3	IPR000859
Domain	TSP_1	ADAMTS13 SSPOP ADAMTSL4	1.54e-04	63	31	3	PF00090
Domain	TSP1	ADAMTS13 SSPOP ADAMTSL4	1.69e-04	65	31	3	SM00209
Domain	TSP1_rpt	ADAMTS13 SSPOP ADAMTSL4	1.69e-04	65	31	3	IPR000884
Domain	TSP1	ADAMTS13 SSPOP ADAMTSL4	1.69e-04	65	31	3	PS50092
Domain	Xlink	STAB2 STAB1	2.06e-04	13	31	2	PF00193
Domain	LINK	STAB2 STAB1	2.06e-04	13	31	2	SM00445
Domain	LINK_1	STAB2 STAB1	2.06e-04	13	31	2	PS01241
Domain	Link_dom	STAB2 STAB1	2.06e-04	13	31	2	IPR000538
Domain	LINK_2	STAB2 STAB1	2.06e-04	13	31	2	PS50963
Domain	LAMININ_NTER	LAMA2 LAMA5	3.15e-04	16	31	2	PS51117
Domain	Laminin_N	LAMA2 LAMA5	3.15e-04	16	31	2	PF00055
Domain	EMI_domain	MEGF6 MEGF11	3.15e-04	16	31	2	IPR011489
Domain	Laminin_N	LAMA2 LAMA5	3.15e-04	16	31	2	IPR008211
Domain	LamNT	LAMA2 LAMA5	3.15e-04	16	31	2	SM00136
Domain	Kringle	MST1 PLG	3.57e-04	17	31	2	IPR000001
Domain	Kringle	MST1 PLG	3.57e-04	17	31	2	PF00051
Domain	KRINGLE_1	MST1 PLG	3.57e-04	17	31	2	PS00021
Domain	Kringle_CS	MST1 PLG	3.57e-04	17	31	2	IPR018056
Domain	KR	MST1 PLG	3.57e-04	17	31	2	SM00130
Domain	KRINGLE_2	MST1 PLG	3.57e-04	17	31	2	PS50070
Domain	ConA-like_dom	LAMA2 LAMA5 TRIM11 SVEP1	4.51e-04	219	31	4	IPR013320
Domain	Galactose-bd-like	LAMA2 LAMA5 SSPOP	5.01e-04	94	31	3	IPR008979
Domain	-	LAMA2 LAMA5 SVEP1	5.17e-04	95	31	3	2.60.120.200
Domain	-	TNC TNXB	7.19e-04	24	31	2	4.10.530.10
Domain	Fibrinogen_a/b/g_C_2	TNC TNXB	7.19e-04	24	31	2	IPR014715
Domain	ADAM_Cys-rich	ADAM33 ADAMTS13	9.12e-04	27	31	2	IPR006586
Domain	Fibrinogen_C	TNC TNXB	9.12e-04	27	31	2	PF00147
Domain	ACR	ADAM33 ADAMTS13	9.12e-04	27	31	2	SM00608
Domain	FBG	TNC TNXB	1.05e-03	29	31	2	SM00186
Domain	-	TNC TNXB	1.13e-03	30	31	2	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	TNC TNXB	1.13e-03	30	31	2	IPR014716
Domain	Fibrinogen_a/b/g_C_dom	TNC TNXB	1.28e-03	32	31	2	IPR002181
Domain	FIBRINOGEN_C_2	TNC TNXB	1.28e-03	32	31	2	PS51406
Domain	Kringle-like	MST1 PLG	1.28e-03	32	31	2	IPR013806
Domain	FIBRINOGEN_C_1	TNC TNXB	1.28e-03	32	31	2	PS00514
Domain	LAM_G_DOMAIN	LAMA2 LAMA5	1.81e-03	38	31	2	PS50025
Domain	DISINTEGRIN_1	ADAM33 ADAMTS13	2.00e-03	40	31	2	PS00427
Domain	Laminin_G_2	LAMA2 LAMA5	2.00e-03	40	31	2	PF02210
Domain	ADAM_MEPRO	ADAM33 ADAMTS13	2.00e-03	40	31	2	PS50215
Domain	DISINTEGRIN_2	ADAM33 ADAMTS13	2.00e-03	40	31	2	PS50214
Domain	Reprolysin	ADAM33 ADAMTS13	2.00e-03	40	31	2	PF01421
Domain	Peptidase_M12B	ADAM33 ADAMTS13	2.00e-03	40	31	2	IPR001590
Domain	Disintegrin_dom	ADAM33 ADAMTS13	2.10e-03	41	31	2	IPR001762
Pathway	REACTOME_ECM_PROTEOGLYCANS	LAMA2 LAMA5 TNC TNXB	6.39e-06	76	23	4	M27219
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	LAMA2 LAMA5 TNC TNXB	9.53e-06	84	23	4	M7098
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS13 SSPOP ADAMTSL4	3.34e-05	39	23	3	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS13 SSPOP ADAMTSL4	3.34e-05	39	23	3	MM15165
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMA2 MST1 LAMA5	5.50e-05	46	23	3	M239
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	LAMA2 LAMA5 PLG TNC TNXB	1.04e-04	300	23	5	M610
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA2 LAMA5 TNC	1.16e-04	59	23	3	M27218
Pathway	PID_INTEGRIN4_PATHWAY	LAMA2 LAMA5	1.39e-04	11	23	2	M158
Pathway	PID_INTEGRIN1_PATHWAY	LAMA2 LAMA5 TNC	1.62e-04	66	23	3	M18
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	ADAMTS13 SSPOP ADAMTSL4	1.77e-04	68	23	3	M27303
Pathway	WP_FOCAL_ADHESION	LAMA2 LAMA5 TNC TNXB	2.18e-04	187	23	4	MM15913
Pathway	KEGG_FOCAL_ADHESION	LAMA2 LAMA5 TNC TNXB	2.76e-04	199	23	4	M7253
Pathway	WP_FOCAL_ADHESION	LAMA2 LAMA5 TNC TNXB	2.76e-04	199	23	4	M39402
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	SCARF1 STAB2 STAB1	5.22e-04	98	23	3	M27152
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS13 SSPOP ADAMTSL4	7.12e-04	109	23	3	MM15164
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	PLG MEGF6 TNC TNXB	7.38e-04	258	23	4	MM14572
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS13 SSPOP ADAMTSL4	7.50e-04	111	23	3	M27416
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	LAMA2 LAMA5	1.08e-03	30	23	2	M27772
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMA2 LAMA5	1.08e-03	30	23	2	M27216
Pathway	PID_SYNDECAN_4_PATHWAY	PLG TNC	1.23e-03	32	23	2	M165
Pathway	WP_ALPHA_6_BETA_4_SIGNALING	LAMA2 LAMA5	1.30e-03	33	23	2	M39503
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	LAMA2 LAMA5 TNC TNXB	1.33e-03	302	23	4	M39719
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	ADAMTS13 SSPOP ADAMTSL4	1.56e-03	143	23	3	M27275
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	LAMA2 LAMA5 TNC TNXB	1.76e-03	326	23	4	MM15917
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	LAMA2 LAMA5	2.01e-03	41	23	2	M27778
Pathway	PID_AMB2_NEUTROPHILS_PATHWAY	MST1 PLG	2.01e-03	41	23	2	M159
Pathway	WP_PI3KAKT_SIGNALING	LAMA2 LAMA5 TNC TNXB	2.03e-03	339	23	4	M39736
Pathway	REACTOME_ECM_PROTEOGLYCANS	TNC TNXB	2.63e-03	47	23	2	MM14925
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	STAB2 STAB1	4.26e-03	60	23	2	MM14872
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	LAMA2 LAMA5	5.13e-03	66	23	2	MM15925
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ADAM33 MEGF6	6.24e-03	73	23	2	MM15126
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	LAMA2 MST1 LAMA5 PLG TNC ADAMTSL4 TNXB	6.68e-11	153	31	7	25037231
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	LAMA2 LAMA5 PLG MEGF6 SSPOP TNC TNXB	1.72e-10	175	31	7	28071719
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	LAMA2 MST1 ADAMTS13 MEGF8 TNC ADAMTSL4 TNXB	2.51e-09	257	31	7	16335952
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	LAMA5 OAZ1 MEGF6 MEGF8 TNC ADAMTSL4 MEGF11 STAB1	2.45e-08	560	31	8	21653829
Pubmed	Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.	LAMA2 LAMA5 TNC	5.37e-08	9	31	3	9882526
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	LAMA2 LAMA5 PLG TNC TNXB	1.28e-07	135	31	5	28675934
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	LAMA2 SSPOP TNC TNXB	3.16e-07	64	31	4	22261194
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	LAMA2 CRISPLD2 LAMA5 ADAMTSL4	7.40e-07	79	31	4	18757743
Pubmed	Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.	STAB2 STAB1	7.69e-07	2	31	2	21293057
Pubmed	The tenascin gene family in axon growth and guidance.	TNC TNXB	7.69e-07	2	31	2	9321695
Pubmed	Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding.	STAB2 STAB1	7.69e-07	2	31	2	15572036
Pubmed	Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.	STAB2 STAB1	7.69e-07	2	31	2	38946049
Pubmed	FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.	STAB2 STAB1	7.69e-07	2	31	2	12473645
Pubmed	The expression pattern of laminin isoforms in Hirschsprung disease reveals a distal peripheral nerve differentiation.	LAMA2 LAMA5	7.69e-07	2	31	2	16226104
Pubmed	Identifying Stabilin-1 and Stabilin-2 Double Knockouts in Reproduction and Placentation: A Descriptive Study.	STAB2 STAB1	7.69e-07	2	31	2	33008099
Pubmed	Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.	STAB2 STAB1	7.69e-07	2	31	2	11829752
Pubmed	Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells.	STAB2 STAB1	7.69e-07	2	31	2	33130055
Pubmed	Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C.	TNC TNXB	7.69e-07	2	31	2	12359049
Pubmed	FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities.	STAB2 STAB1	7.69e-07	2	31	2	12077138
Pubmed	Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.	TNC TNXB	7.69e-07	2	31	2	17202312
Pubmed	Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen).	ADAMTS13 PLG	7.69e-07	2	31	2	22685231
Pubmed	Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts.	TNC TNXB	7.69e-07	2	31	2	8856503
Pubmed	The change in tenascin expression in mouse uterus during early pregnancy.	TNC TNXB	7.69e-07	2	31	2	9013311
Pubmed	Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice.	STAB2 STAB1	7.69e-07	2	31	2	37446152
Pubmed	Distribution of tenascin-C and -X, and soft X-ray analysis of the mandibular symphysis during mandible formation in the human fetus.	TNC TNXB	7.69e-07	2	31	2	15455729
Pubmed	Tenascin variants: ligands and expression.	TNC TNXB	7.69e-07	2	31	2	7509489
Pubmed	The effects of tenascin C knockdown on trabecular meshwork outflow resistance.	TNC TNXB	7.69e-07	2	31	2	23882691
Pubmed	Scavenging Endothelium of Pancreatic Islets: Differential Expression of Stabilin-1 and Stabilin-2 in Mice and Humans.	STAB2 STAB1	7.69e-07	2	31	2	27977633
Pubmed	Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver.	STAB2 STAB1	7.69e-07	2	31	2	21427291
Pubmed	Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.	LAMA2 LAMA5 TNC	1.46e-06	25	31	3	19373938
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	LAMA2 LAMA5 TNC TNXB	1.69e-06	97	31	4	27559042
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	DLK2 CRISPLD2 C1QTNF8 ADAM33 ADAMTS13 ADAMTSL4 MEGF11 IL21R	1.78e-06	985	31	8	12975309
Pubmed	Tenascins and osteopontin in biological response in cornea.	TNC TNXB	2.31e-06	3	31	2	37209968
Pubmed	Expression of tenascin in developing and adult mouse lymphoid organs.	TNC TNXB	2.31e-06	3	31	2	7687262
Pubmed	Highly oxidized albumin is cleared by liver sinusoidal endothelial cells via the receptors stabilin-1 and -2.	STAB2 STAB1	2.31e-06	3	31	2	37926735
Pubmed	The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse.	TNC TNXB	2.31e-06	3	31	2	12823230
Pubmed	Laminin α2, α4, and α5 Chains Positively Regulate Migration and Survival of Oligodendrocyte Precursor Cells.	LAMA2 LAMA5	2.31e-06	3	31	2	31882770
Pubmed	The tenascin gene family.	TNC TNXB	2.31e-06	3	31	2	7530141
Pubmed	Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.	TNC TNXB	2.31e-06	3	31	2	7694605
Pubmed	Developmental expression and cellular origin of the laminin alpha2, alpha4, and alpha5 chains in the intestine.	LAMA2 LAMA5	2.31e-06	3	31	2	10364433
Pubmed	Stabilin receptors clear LPS and control systemic inflammation.	STAB2 STAB1	2.31e-06	3	31	2	34816100
Pubmed	Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.	ADAMTS13 PLG	2.31e-06	3	31	2	24449821
Pubmed	Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression.	STAB2 STAB1	4.61e-06	4	31	2	36325910
Pubmed	Deficiency for scavenger receptors Stabilin-1 and Stabilin-2 leads to age-dependent renal and hepatic depositions of fasciclin domain proteins TGFBI and Periostin in mice.	STAB2 STAB1	4.61e-06	4	31	2	37357460
Pubmed	An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.	LAMA2 LAMA5	4.61e-06	4	31	2	11565031
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	LAMA2 TNC	4.61e-06	4	31	2	34504132
Pubmed	Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach.	LAMA2 LAMA5	7.68e-06	5	31	2	11969289
Pubmed	Tissue-specific expression of the human laminin alpha5-chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near the locus for the ragged (Ra) mutation.	LAMA2 LAMA5	7.68e-06	5	31	2	9271224
Pubmed	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.	LAMA2 LAMA5	7.68e-06	5	31	2	11829758
Pubmed	Polydom/SVEP1 is a ligand for integrin α9β1.	TNC SVEP1	7.68e-06	5	31	2	22654117
Pubmed	The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.	TNC TNXB	7.68e-06	5	31	2	7512972
Pubmed	Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney.	LAMA2 LAMA5	7.68e-06	5	31	2	9415429
Pubmed	Differential expression of laminin alpha chains during murine tooth development.	LAMA2 LAMA5	7.68e-06	5	31	2	9389447
Pubmed	Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis.	STAB2 STAB1	7.68e-06	5	31	2	15907457
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	LAMA2 LAMA5 TNC TNXB	8.59e-06	146	31	4	27068509
Pubmed	A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction.	LAMA2 LAMA5	1.15e-05	6	31	2	18817539
Pubmed	HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.	LAMA2 LAMA5	1.15e-05	6	31	2	9597096
Pubmed	Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion.	TNC TNXB	1.15e-05	6	31	2	7512897
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ADAM33 OAZ1 MEGF6 MEGF8 SSPOP MEGF11	1.41e-05	608	31	6	16713569
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	LAMA2 LAMA5 PLG TNC	1.46e-05	167	31	4	22159717
Pubmed	Laminin isoforms in fetal and adult human adrenal cortex.	LAMA2 LAMA5	1.61e-05	7	31	2	14557481
Pubmed	Transforming Growth Factor-Beta and Sonic Hedgehog Signaling in Palatal Epithelium Regulate Tenascin-C Expression in Palatal Mesenchyme During Soft Palate Development.	TNC TNXB	1.61e-05	7	31	2	32581832
Pubmed	Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice.	LAMA2 LAMA5	1.61e-05	7	31	2	9390664
Pubmed	Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain.	LAMA2 LAMA5	2.15e-05	8	31	2	9852162
Pubmed	Beta1 integrins are required for the invasion of the caecum and proximal hindgut by enteric neural crest cells.	LAMA5 TNC	2.15e-05	8	31	2	19633172
Pubmed	Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells.	LAMA2 LAMA5	2.15e-05	8	31	2	10102687
Pubmed	Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.	LAMA2 LAMA5	2.15e-05	8	31	2	8872465
Pubmed	Mice develop normally without tenascin.	TNC TNXB	2.15e-05	8	31	2	1383086
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	LAMA5 PRMT7 CSMD2	2.46e-05	63	31	3	11572484
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	MEGF6 MEGF8	2.76e-05	9	31	2	9693030
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA2 LAMA5	3.44e-05	10	31	2	9034910
Pubmed	Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro.	LAMA2 LAMA5	3.44e-05	10	31	2	18590826
Pubmed	Trophoblast-specific expression and function of the integrin alpha 7 subunit in the peri-implantation mouse embryo.	LAMA2 LAMA5	3.44e-05	10	31	2	11784026
Pubmed	Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.	LAMA2 LAMA5	3.44e-05	10	31	2	20976766
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADAMTS13 SSPOP ADAMTSL4	4.15e-05	75	31	3	20637190
Pubmed	Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung.	LAMA2 LAMA5	4.21e-05	11	31	2	12051813
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA2 LAMA5	4.21e-05	11	31	2	21524702
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA2 LAMA5	4.21e-05	11	31	2	23472759
Pubmed	Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.	LAMA2 LAMA5	5.05e-05	12	31	2	11381080
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA2 LAMA5	5.05e-05	12	31	2	16750824
Pubmed	Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids.	LAMA5 TNC	5.05e-05	12	31	2	10090148
Pubmed	YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis.	TNC TNXB	5.05e-05	12	31	2	10101119
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMA2 LAMA5	5.05e-05	12	31	2	9396756
Pubmed	The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut.	LAMA2 LAMA5	5.96e-05	13	31	2	36350252
Pubmed	Fukutin-related protein alters the deposition of laminin in the eye and brain.	LAMA2 LAMA5	5.96e-05	13	31	2	21900571
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	TNC ADAMTSL4 TNXB	6.24e-05	86	31	3	28327460
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	LAMA2 TNC ADAMTSL4 SVEP1	6.82e-05	248	31	4	24006456
Pubmed	The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.	LAMA2 LAMA5	6.95e-05	14	31	2	9151674
Pubmed	Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane.	LAMA2 LAMA5	8.02e-05	15	31	2	10625553
Pubmed	Laminin alpha5 chain is required for intestinal smooth muscle development.	LAMA2 LAMA5	8.02e-05	15	31	2	12921739
Pubmed	Localization of basement membrane-associated protein isoforms during development of the ocular surface of mouse eye.	LAMA2 LAMA5	8.02e-05	15	31	2	9264260
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMA2 LAMA5	8.02e-05	15	31	2	15895400
Pubmed	Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.	LAMA2 TNC	8.02e-05	15	31	2	19793892
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMA2 LAMA5	9.16e-05	16	31	2	17601529
Pubmed	Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation.	LAMA5 TNC	9.16e-05	16	31	2	21067603
Pubmed	Mechanical loading is required for initiation of extracellular matrix deposition at the developing murine myotendinous junction.	LAMA2 TNC	9.16e-05	16	31	2	36709857
Pubmed	Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.	LAMA5 SVEP1	9.16e-05	16	31	2	28179430
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	LAMA5 TNC TNXB	1.01e-04	101	31	3	20551380
Pubmed	Laminin α1 is essential for mouse cerebellar development.	LAMA2 LAMA5	1.04e-04	17	31	2	21983115
Pubmed	Beta1-integrins are critical for cerebellar granule cell precursor proliferation.	LAMA2 LAMA5	1.04e-04	17	31	2	15056720
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	SCARF1 STAB2 STAB1	4.49e-06	27	22	3	1253
GeneFamily	Laminin subunits	LAMA2 LAMA5	9.26e-05	12	22	2	626
GeneFamily	Fibrinogen C domain containing	TNC TNXB	4.17e-04	25	22	2	554
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 SVEP1	2.17e-03	57	22	2	1179
GeneFamily	Ring finger proteins	RNF224 TRIM11 RNF19B	4.33e-03	275	22	3	58
GeneFamily	Fibronectin type III domain containing	TNC TNXB	1.60e-02	160	22	2	555
Coexpression	NABA_MATRISOME	LAMA2 MST1 CRISPLD2 LAMA5 C1QTNF8 ADAM33 ADAMTS13 PLG MEGF6 MEGF8 SSPOP TNC ADAMTSL4 TNXB MEGF11 SVEP1	4.69e-15	1026	31	16	M5889
Coexpression	NABA_MATRISOME	LAMA2 MST1 CRISPLD2 LAMA5 ADAM33 ADAMTS13 PLG MEGF6 MEGF8 SSPOP TNC ADAMTSL4 TNXB MEGF11 SVEP1	9.07e-14	1008	31	15	MM17056
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 CRISPLD2 LAMA5 SSPOP TNC TNXB SVEP1	2.22e-09	191	31	7	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 CRISPLD2 LAMA5 SSPOP TNC TNXB SVEP1	2.65e-09	196	31	7	M3008
Coexpression	NABA_CORE_MATRISOME	LAMA2 CRISPLD2 LAMA5 SSPOP TNC TNXB SVEP1	2.42e-08	270	31	7	MM17057
Coexpression	NABA_CORE_MATRISOME	LAMA2 CRISPLD2 LAMA5 SSPOP TNC TNXB SVEP1	2.75e-08	275	31	7	M5884
Coexpression	NABA_MATRISOME_ASSOCIATED	MST1 C1QTNF8 ADAM33 ADAMTS13 PLG MEGF6 MEGF8 ADAMTSL4 MEGF11	1.42e-07	751	31	9	M5885
Coexpression	NABA_MATRISOME_ASSOCIATED	MST1 ADAM33 ADAMTS13 PLG MEGF6 MEGF8 ADAMTSL4 MEGF11	1.69e-06	738	31	8	MM17058
Coexpression	GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	SCARF1 STAB2 REXO1 MEGF11	3.19e-05	154	31	4	M6824
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	LAMA2 MST1 STAB2 PRMT7 MEGF6 MEGF8 TNXB	7.48e-05	909	31	7	M41018
Coexpression	GSE11057_CD4_EFF_MEM_VS_PBMC_DN	CRISPLD2 OAZ1 ADGRE2 ADAMTSL4	7.83e-05	194	31	4	M3114
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST	ADAM33 ADAMTSL4 TNXB	8.11e-05	71	31	3	M45664
Coexpression	BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS	LAMA5 MEGF6 TNC	1.03e-04	77	31	3	M40001
Coexpression	ROSS_AML_WITH_PML_RARA_FUSION	MST1 MEGF6 STAB1	1.16e-04	80	31	3	M15368
Coexpression	HEBERT_MATRISOME_TNBC_LIVER_METASTASIS	PLG TNC	1.22e-04	14	31	2	M48002
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL	MST1 LAMA5 ADAM33 MEGF6 ADAMTSL4 TNXB	1.52e-04	704	31	6	M45672
Coexpression	NABA_ECM_REGULATORS	ADAM33 ADAMTS13 PLG ADAMTSL4	1.72e-04	238	31	4	M3468
Coexpression	NABA_ECM_REGULATORS	ADAM33 ADAMTS13 PLG ADAMTSL4	1.83e-04	242	31	4	MM17062
Coexpression	HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN	SCARF1 ADGRE2 ADAMTSL4 STAB1	2.34e-04	258	31	4	M41144
Coexpression	BOQUEST_STEM_CELL_UP	LAMA2 CRISPLD2 TNC SVEP1	2.45e-04	261	31	4	M1834
Coexpression	NABA_MATRISOME_BLEO_FIBROTIC_LUNG	LAMA5 TNC	2.54e-04	20	31	2	MM17053
Coexpression	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	STAB2 PLG SH3TC1 STAB1	2.94e-04	274	31	4	M13014
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN	STAB2 MEGF8 MEGF11	2.97e-04	110	31	3	M8946
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	LAMA5 TNXB	3.37e-04	23	31	2	M48001
Coexpression	BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP	CRISPLD2 ADGRE2 TNC IL21R	3.46e-04	286	31	4	M34008
Coexpression	NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER	LAMA2 TNXB	3.99e-04	25	31	2	M47986
Coexpression	DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC	PLG TNC	4.66e-04	27	31	2	M47994
Coexpression	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	LAMA5 PLG STAB1	5.40e-04	135	31	3	M5825
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	LAMA2 CRISPLD2 LAMA5 TNC TNXB SVEP1	2.86e-05	453	29	6	GSM777067_500
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	LAMA2 CRISPLD2 LAMA5 TNC TNXB SVEP1	3.35e-05	466	29	6	GSM777050_500
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_200	SCARF1 STAB2 STAB1	1.69e-04	79	29	3	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000	LAMA2 TNC ADAMTSL4 TNXB	2.53e-04	229	29	4	gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	STAB2 TNC STAB1	2.57e-04	91	29	3	GSM777059_100
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	STAB2 TNC STAB1	3.00e-04	96	29	3	GSM777063_100
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	LAMA2 CRISPLD2 TNC TNXB SVEP1	3.10e-04	445	29	5	GSM777043_500
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	SCARF1 STAB2 SH3TC1 TNC STAB1	3.26e-04	450	29	5	GSM777063_500
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 ADAMTS13 TNC TNXB	2.64e-09	181	31	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	3.21e-09	187	31	6	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	SCARF1 LAMA2 CRISPLD2 ADAM33 MEGF6 SH3TC1	3.32e-09	188	31	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 ADAM33 MEGF6 TNXB SVEP1	3.65e-09	191	31	6	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 ADAM33 MEGF6 TNXB SVEP1	3.88e-09	193	31	6	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	LAMA2 CRISPLD2 ADAMTS13 TNC TNXB SVEP1	4.52e-09	198	31	6	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	LAMA2 CRISPLD2 ADAMTS13 TNC TNXB SVEP1	4.52e-09	198	31	6	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	db6281b5d4032116310db379d9175d790994c99c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	cfea2f9d85646c9b722150551ff2e8fc4f6cc98a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	5'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNC TNXB SVEP1	4.80e-09	200	31	6	6e3d1ae0ef84d3075afa40129a41169996462672
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB SVEP1	4.80e-09	200	31	6	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.07e-07	168	31	5	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.17e-07	171	31	5	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 P2RY11 TNC SVEP1	1.17e-07	171	31	5	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 P2RY11 TNC SVEP1	1.17e-07	171	31	5	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.21e-07	172	31	5	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SCARF1 ADGRE2 CSMD2 SVEP1 IL21R	1.47e-07	179	31	5	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	LAMA2 CRISPLD2 ADAM33 ADAMTSL4 TNXB	1.47e-07	179	31	5	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 TNC TNXB SVEP1	1.60e-07	182	31	5	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA2 CRISPLD2 ADAM33 TNC TNXB	1.64e-07	183	31	5	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.69e-07	184	31	5	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 CSMD2 TNXB SVEP1	1.73e-07	185	31	5	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA2 ADAM33 ADAMTS13 TNC TNXB	1.73e-07	185	31	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.73e-07	185	31	5	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.73e-07	185	31	5	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 TNC TNXB SVEP1	1.78e-07	186	31	5	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.78e-07	186	31	5	7582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.78e-07	186	31	5	07d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 TNC TNXB SVEP1	1.83e-07	187	31	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.88e-07	188	31	5	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.88e-07	188	31	5	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 ADAM33 MEGF6 TNXB SVEP1	1.88e-07	188	31	5	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.93e-07	189	31	5	d531399749409d614adca13d181830c6e3287508
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	1.98e-07	190	31	5	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 ADAM33 MEGF6 TNXB SVEP1	1.98e-07	190	31	5	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.09e-07	192	31	5	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.09e-07	192	31	5	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.09e-07	192	31	5	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.09e-07	192	31	5	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.09e-07	192	31	5	04d155897ed075c359933080e36a4ab2150b6e9f
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.09e-07	192	31	5	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.14e-07	193	31	5	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.14e-07	193	31	5	0a665531d581d4e3941e29d3f95569da8f166447
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.14e-07	193	31	5	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.14e-07	193	31	5	24ce1f37cca655415410d2403a52d1ebb3332280
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.14e-07	193	31	5	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.20e-07	194	31	5	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.20e-07	194	31	5	2d0cff9dc538a14518741e2a96d9d78442c81a72
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.25e-07	195	31	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.25e-07	195	31	5	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRISPLD2 ADAM33 TNC TNXB SVEP1	2.25e-07	195	31	5	47762d9e442fb1f6f0033e3e10f4c6e498d2c081
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.25e-07	195	31	5	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.25e-07	195	31	5	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.31e-07	196	31	5	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	LAMA2 CRISPLD2 CSMD2 TNC SVEP1	2.37e-07	197	31	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.37e-07	197	31	5	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	LAMA2 CRISPLD2 ADAM33 TNC SVEP1	2.43e-07	198	31	5	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.43e-07	198	31	5	abac765c4f6864bdb1700bc546c3b9771edc25c3
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.43e-07	198	31	5	ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.43e-07	198	31	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	5'-Parenchyma_lung-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.43e-07	198	31	5	aae663c6da70b6e716edeed50cc7d3962d78e697
ToppCell	3'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.43e-07	198	31	5	698166b4ca173176ed563af6a1efc8c7d0a18e0b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	4032f03a4165f5f2a90ef1d8315cc743ce9075bb
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	1fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNC SVEP1	2.49e-07	199	31	5	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	LAMA2 CRISPLD2 TNC TNXB SVEP1	2.49e-07	199	31	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 C1QTNF8 TNC SVEP1	2.49e-07	199	31	5	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	4e128c705ad36fd840582848f278770f356fcc8b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LAMA2 CRISPLD2 ADAMTS13 TNC TNXB	2.49e-07	199	31	5	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.49e-07	199	31	5	a538da095ba996ee96e263442cf5b6ba9178f3d4
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	LAMA2 CRISPLD2 ADGRE2 TNC SVEP1	2.49e-07	199	31	5	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	3'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.55e-07	200	31	5	87177c973e722ac7d9ee503b9cfacd84fc67865d
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	8d75ce89393df452defacf2ec9a5bd4b7708afbb
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	28e5354008adf97b17333f17f8cbef930db6729a
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Tracheal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	f74b9b0e27afedd589e828d30194e8417029817a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.55e-07	200	31	5	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Biopsy_IPF-Mesenchymal-Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	b04831708fa20471a127b87e8db3728b6e729ce8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	17ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 CRISPLD2 ADAM33 TNXB SVEP1	2.55e-07	200	31	5	6316c288022719b9e6c4332c5cb9041e1188d0e8
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	LAMA2 CRISPLD2 ADAMTS13 TNC TNXB	2.55e-07	200	31	5	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.55e-07	200	31	5	cbf6a6c3db88bac37bd084a3a914b12b3af524eb
ToppCell	5'-Adult-SmallIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 CRISPLD2 ADAMTSL4 TNXB SVEP1	2.55e-07	200	31	5	a637281d91e95734ee4f8510b3780e0272b16fda
Computational	Adhesion molecules.	LAMA2 LAMA5 TNC TNXB	9.44e-05	141	19	4	MODULE_122
Drug	LMWH	SCARF1 LAMA2 LAMA5 ADAMTS13 PLG TNC ADAMTSL4 TNXB	2.16e-06	663	31	8	CID000000772
Drug	3-ethylpyridine	TNC TNXB	1.07e-05	4	31	2	CID000010823
Drug	dermatan sulfate	LAMA5 PLG ADGRE2 TNC TNXB	1.11e-05	220	31	5	CID000032756
Drug	Gdrgdsp	LAMA5 TNC ADAMTSL4 TNXB	1.42e-05	109	31	4	CID000115346
Drug	Rgd Peptide	LAMA5 PLG TNC ADAMTSL4 TNXB	1.66e-05	239	31	5	CID000104802
Drug	chondroitin sulfate	LAMA5 PLG ADGRE2 TNC ADAMTSL4 TNXB	1.72e-05	413	31	6	CID000024766
Drug	AC1O5SNJ	TNC TNXB	2.68e-05	6	31	2	CID006439900
Drug	kalinin	LAMA2 LAMA5 TNC	5.72e-05	55	31	3	CID000032518
Drug	pyrachlostrobin	CRISPLD2 LAMA5 SH3TC1 TNC ADAMTSL4 SVEP1 STAB1	8.82e-05	811	31	7	ctd:C513428
Drug	AC1L1G72	LAMA2 LAMA5	9.79e-05	11	31	2	CID000003553
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A	LAMA2 ADAMTS13 SH3TC1 IL21R	9.85e-05	179	31	4	4762_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	LAMA2 STAB2 SH3TC1 SVEP1	1.32e-04	193	31	4	6189_UP
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	MEGF6 TNC SVEP1 RNF19B	1.34e-04	194	31	4	2825_UP
Drug	Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A	CRISPLD2 PLG MEGF8 IL21R	1.34e-04	194	31	4	3213_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A	SCARF1 MEGF6 SH3TC1 STAB1	1.37e-04	195	31	4	4148_UP
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	LAMA2 STAB2 ADGRE2 SVEP1	1.37e-04	195	31	4	3821_DN
Drug	dysprosium	LAMA2 LAMA5 PLG	1.39e-04	74	31	3	CID000023912
Drug	Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A	STAB2 ADAMTSL4 SVEP1 IL21R	1.40e-04	196	31	4	3122_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A	DLK2 SH3TC1 SVEP1 RNF19B	1.40e-04	196	31	4	3702_DN
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A	DLK2 MEGF8 SVEP1 RNF19B	1.40e-04	196	31	4	2800_UP
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	DLK2 STAB2 MEGF6 MEGF8	1.42e-04	197	31	4	7533_DN
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A	CRISPLD2 STAB2 SH3TC1 STAB1	1.42e-04	197	31	4	2156_UP
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	LAMA2 ADAMTSL4 IL21R STAB1	1.42e-04	197	31	4	5685_UP
Drug	Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	LAMA2 PLG MEGF6 IL21R	1.42e-04	197	31	4	3681_UP
Drug	C75; Up 200; 10uM; PC3; HT_HG-U133A	PLG SH3TC1 SVEP1 IL21R	1.42e-04	197	31	4	6399_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	STAB2 SVEP1 RNF19B STAB1	1.48e-04	199	31	4	6357_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A	CRISPLD2 ADAMTSL4 SVEP1 STAB1	1.51e-04	200	31	4	2348_UP
Disease	tenascin measurement	TNC TNXB	4.18e-05	10	29	2	EFO_0008296
Disease	multiple sclerosis symptom measurement	CRISPLD2 STAB2	9.40e-04	46	29	2	EFO_0803536
Disease	von Willebrand factor measurement	ADAMTS13 STAB2	1.39e-03	56	29	2	EFO_0004629
Disease	response to lithium ion	MEGF6 CSMD2	1.39e-03	56	29	2	GO_0010226

Protein segments in the cluster

Peptide	Gene	Start	Entry
EPCHGTPCPPYWEAG	ADAMTSL4	716	Q6UY14
RWNYPPPLCIAQCGG	CSMD2	1956	Q7Z408
SYQCRCRPGWQPIPG	ADGRE2	186	Q9UHX3
PCARGSGYCWDGACP	ADAM33	506	Q9BZ11
PCPPYWAVGDFGPCS	ADAMTS13	741	Q76LX8
RCDSTCPPGRWGPNC	MEGF11	561	A6BM72
ACPPGFWGPACFHAC	MEGF11	696	A6BM72
CCRHCPGYRDSWNPE	P2RY11	331	Q96G91
PYPSECNPWCPERCS	CRISPLD2	141	Q9H0B8
QCQPPGVCACEPGWG	MEGF8	151	Q7Z7M0
CPPGYTGSSCESCWP	LAMA2	726	P24043
CATGYWGFPNCRPCD	LAMA5	1471	O15230
GPQCRECAPGYWGLP	LAMA5	2096	O15230
ECAPGYWGLPEQGCR	LAMA5	2101	O15230
CCSNPGPGPRWCSDA	OAZ1	56	P54368
EPADPEGGCCWNPHC	PRMT7	631	Q9NVM4
CVHCCRPAWPPGPYA	C1QTNF8	26	P60827
GPCTWPCSCEDDGYP	IL21R	386	Q9HBE5
AWRRGVCPPGPCCYP	DLK2	331	Q6UY11
FCRNPDGDPGGPWCY	MST1	156	P26927
CPPWAFGPGCSEECQ	MEGF6	641	O75095
IDCPYWSGAPGGPCR	REXO1	11	Q8N1G1
WSGAPGGPCRRPYCH	REXO1	16	Q8N1G1
PDCRWCPAPDCGYAV	RNF19B	201	Q6ZMZ0
VTCPPDWPCGSPGCW	SSPOP	1836	A2VEC9
DWPCGSPGCWCPEGQ	SSPOP	1841	A2VEC9
HCVWRCQPGCYCPPG	SSPOP	3336	A2VEC9
PHFPQPRYCCWGCGS	RNF224	131	P0DH78
PRYCCWGCGSLCCPP	RNF224	136	P0DH78
CPGCPQEPASWGLCA	SH3TC1	456	Q8TE82
CRNPDGDVGGPWCYT	PLG	531	P00747
APYQCDCPPGWTGSR	SVEP1	3516	Q4LDE5
CSSRCPGQYWGPDCR	SCARF1	86	Q14162
PGQYWGPDCRESCPC	SCARF1	91	Q14162
RRCWGQPEGPYACPE	TRIM11	41	Q96F44
RCVCFPGYTGPSCGW	TNXB	201	P22105
PSCGWPSCPGDCQGR	TNXB	211	P22105
CEPGWKGPNCSEPEC	TNC	176	P24821
CPGYWGSRCHECPGG	STAB1	101	Q9NY15
CPGRWGPDCIECPGG	STAB2	101	Q8WWQ8
WPGRFGPDCLPCGCS	STAB2	2001	Q8WWQ8